Skip to content
10-Q

Quarterly Report

GFR PHARMACEUTICALS INC

0001437749-12-011642

← back to feed
Filed
Nov 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Nov 13, 2012 42.08M sh
Capex Q3 2012 · Sep 30, 2012 $1.49K
Capex Q3 2012 · Sep 30, 2011 $302.37K
Operating Cash Flow Q3 2012 · Sep 30, 2012 $391.82K
Operating Cash Flow Q3 2012 · Sep 30, 2011 $471.5K
Cash And Equivalents Q3 2012 · Sep 30, 2012 $853.69K
Cash And Equivalents Q3 2012 · Dec 31, 2011 $460.88K
Cash And Equivalents Q3 2012 · Sep 30, 2011 $448.02K
Cash And Equivalents Q3 2012 · Dec 31, 2010 $300.72K
Stockholders Equity Q3 2012 · Sep 30, 2012 $9.7M
Stockholders Equity Q3 2012 · Dec 31, 2011 $8.52M
Current Liabilities Q3 2012 · Sep 30, 2012 $828.84K
Current Liabilities Q3 2012 · Dec 31, 2011 $2.28M
Total Liabilities Q3 2012 · Sep 30, 2012 $1.67M
Total Liabilities Q3 2012 · Dec 31, 2011 $3.12M
Current Assets Q3 2012 · Sep 30, 2012 $1.68M
Current Assets Q3 2012 · Dec 31, 2011 $1.09M
Total Assets Q3 2012 · Sep 30, 2012 $12.12M
Total Assets Q3 2012 · Dec 31, 2011 $12.33M
Sga Expense Q3 2012 · Sep 30, 2012 $177.65K
Sga Expense Q3 2012 · Sep 30, 2012 $609.16K
Sga Expense Q3 2012 · Sep 30, 2011 $134.02K
Sga Expense Q3 2012 · Sep 30, 2011 $521.67K
Net Income Q3 2012 · Sep 30, 2012 $321.42K
Net Income Q3 2012 · Sep 30, 2012 $1.16M
Net Income Q3 2012 · Sep 30, 2011 $622.74K
Net Income Q3 2012 · Sep 30, 2011 $1.67M
Operating Income Q3 2012 · Sep 30, 2012 $431.99K
Operating Income Q3 2012 · Sep 30, 2012 $1.58M
Operating Income Q3 2012 · Sep 30, 2011 $832.98K
Operating Income Q3 2012 · Sep 30, 2011 $2.21M
Gross Profit Q3 2012 · Sep 30, 2012 $672.14K
Gross Profit Q3 2012 · Sep 30, 2012 $2.39M
Gross Profit Q3 2012 · Sep 30, 2011 $983.68K
Gross Profit Q3 2012 · Sep 30, 2011 $2.73M
Cost Of Revenue Q3 2012 · Sep 30, 2012 $393.99K
Cost Of Revenue Q3 2012 · Sep 30, 2012 $787.36K
Cost Of Revenue Q3 2012 · Sep 30, 2011 $188.45K
Cost Of Revenue Q3 2012 · Sep 30, 2011 $595.09K